Hepatitis C virus
Showing 26 - 50 of >10,000
Metabolic Syndrome and Long-term Survival Following Liver
Recruiting
- Survival
-
Assiut, EgyptAhmed Mohammed Abu-Elfatth
Oct 2, 2022
Kidney Failure Trial in Loma Linda (Kidney Transplantation)
Enrolling by invitation
- Kidney Failure
- Kidney Transplantation
-
Loma Linda, CaliforniaLoma Linda University Health-Transplant Institute
Nov 29, 2022
Protect Egyptian Population Against Severe Corona Virus
Completed
- Corona Virus Infection
- Hepatitis
-
Zagazig, Sharkia, EgyptZagazig University Hospitals
Sep 28, 2022
Hepatitis C, Chronic, Substance Use Disorders Trial in Roanoke (Peer specialist (PS) and vouchers)
Not yet recruiting
- Hepatitis C, Chronic
- Substance Use Disorders
- Peer specialist (PS) and vouchers
-
Roanoke, VirginiaCarilion Clinic
May 25, 2022
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Zepatier in Patients With Substance Use
Active, not recruiting
- Hepatitis C
- +3 more
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jun 28, 2022
Hepatitis C Virus-infected Cirrhosis Trial in Tokyo (PRI-724)
Completed
- Hepatitis C Virus-infected Cirrhosis
-
Tokyo, JapanTokyo metropolitan Komagome Hospital
Jul 4, 2022
Hepatitis C Virus Trial in Aurora (ribavirin)
Completed
- Hepatitis C Virus
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 20, 2021
Hepatitis C Screening Paired With Mammography
Recruiting
- Hepatitis C
- Breast Cancer
-
Montpellier, Occitanie, France
- +3 more
Mar 30, 2022
Sofosbuvir/Daclatasvir in HCV-infected Lactating Women
Recruiting
- Hepatitis C Virus Infection
- Pharmacokinetic test
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Aug 21, 2022
Possible Differences in HCC Course Depending on DAA Treatment
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Direct Acting Antivirals
-
Warsaw, Mazowieckie, PolandMedical University of Warsaw
May 11, 2022
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- (no location specified)
Jul 14, 2021
Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual
Recruiting
- Hepatitis C Virus Infection, Response to Therapy of
- Test and treat plus peer mentors
- Usual care
-
Birmingham, Alabama
- +3 more
Dec 9, 2022
HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)
Withdrawn
- HIV Infections
- +2 more
- Adefovir dipivoxil
- +3 more
- (no location specified)
Oct 28, 2021
Viral Hepatitis B, C and HIV Among Drug Users in
Recruiting
- Hepatitis C
- +4 more
-
Limoges, Haute Vienne, FranceChu Limoges
May 3, 2022
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Screening, Treatment, and Eradication of Hep C
Not yet recruiting
- Hepatitis C Virus Infection
- Hepatitis C Virus Screening
- (no location specified)
Sep 27, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C Infection Trial in Richmond (HCVax)
Recruiting
- Chronic Hepatitis C Infection
- HCVax
-
Richmond, VirginiaVirginia Commonwealth University, Medical Center
Sep 28, 2021
Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)
Completed
- Chronic Hepatitis C Virus (HCV) Infection
- ABT-493/ABT-530
- Placebo for ABT-493/ABT-530
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)
Completed
- Hepatitis C, Chronic
- Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
-
Mansoura, EgyptMansoura University Children Hospital
Oct 21, 2021